Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

A. Chanan-Khan; M. Egyed; T. Robak; F. A. Martinelli De Oliveira; M. A. Echeveste; S. Dolan; P. Desjardins; J. Z. Blonski; J. Mei; N. Golany; J. Zhang; J. G. Gribben

doi:10.1038/leu.2017.47

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

A. Chanan-Khan, M. Egyed, T. Robak, F. A. Martinelli De Oliveira, M. A. Echeveste, S. Dolan, P. Desjardins, J. Z. Blonski, J. Mei, N. Golany, J. Zhang, J. G. Gribben

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	1240-1243
Number of pages	4
Journal	Leukemia
Volume	31
Issue number	5
DOIs	https://doi.org/10.1038/leu.2017.47
State	Published - May 1 2017

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2017.47

Cite this

Chanan-Khan, A., Egyed, M., Robak, T., Martinelli De Oliveira, F. A., Echeveste, M. A., Dolan, S., Desjardins, P., Blonski, J. Z., Mei, J., Golany, N., Zhang, J., & Gribben, J. G. (2017). Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial). Leukemia, 31(5), 1240-1243. https://doi.org/10.1038/leu.2017.47

Chanan-Khan, A, Egyed, M, Robak, T, Martinelli De Oliveira, FA, Echeveste, MA, Dolan, S, Desjardins, P, Blonski, JZ, Mei, J, Golany, N, Zhang, J & Gribben, JG 2017, 'Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)', Leukemia, vol. 31, no. 5, pp. 1240-1243. https://doi.org/10.1038/leu.2017.47

@article{9bf3a7de524a4b9f806ff632d9abf83b,

title = "Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)",

author = "A. Chanan-Khan and M. Egyed and T. Robak and {Martinelli De Oliveira}, {F. A.} and Echeveste, {M. A.} and S. Dolan and P. Desjardins and Blonski, {J. Z.} and J. Mei and N. Golany and J. Zhang and Gribben, {J. G.}",

year = "2017",

month = may,

day = "1",

doi = "10.1038/leu.2017.47",

language = "English (US)",

volume = "31",

pages = "1240--1243",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

AU - Chanan-Khan, A.

AU - Egyed, M.

AU - Robak, T.

AU - Martinelli De Oliveira, F. A.

AU - Echeveste, M. A.

AU - Dolan, S.

AU - Desjardins, P.

AU - Blonski, J. Z.

AU - Mei, J.

AU - Golany, N.

AU - Zhang, J.

AU - Gribben, J. G.

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85013077979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013077979&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.47

DO - 10.1038/leu.2017.47

M3 - Letter

C2 - 28140392

AN - SCOPUS:85013077979

SN - 0887-6924

VL - 31

SP - 1240

EP - 1243

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this